Bioabsorbable Stent/Bioresorbable Scaffold Market is Determined to Cross US$ 417 Million By 2022



New York, June 14, 2018: The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Abbott Laboratories (U.S.), BIOTRONIK SE & Co. KG (Germany), REVA Medical, Inc. (U.S.), Elixir Medical Corporation (U.S.), and Kyoto Medical Planning Co., Ltd. (Japan). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The scope of the report includes a detailed study of Bioabsorbable Stent/Bioresorbable Scaffold Market with the reasons given for variations in the growth of the industry in certain regions.
The Bioabsorbable Stent/Bioresorbable Scaffold Market is expected to exceed more than US$ 417 Million by 2022 at a CAGR of 11% in the given forecast period.


This report provides:

1) An overview of the global market for Bioabsorbable Stent/Bioresorbable Scaffold Market.
2) Analyses of global market trends, with data from 2015, estimates for 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022.
3) Identifications of new market opportunities and targeted promotional plans for Bioabsorbable Stent/Bioresorbable Scaffold Market
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.

Reasons to Buy this Report: 

1) Obtain the most up to date information available on all Bioabsorbable Stent/Bioresorbable Scaffold Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Bioabsorbable Stent/Bioresorbable Scaffold Market.
4) Assess your competitor’s refining portfolio and its evolution.

The Bioabsorbable Stent/Bioresorbable Scaffold Market has been segmented as below:

By Application Type:
  • Coronary Artery Diseases
  • Peripheral Artery Diseases
By Material type:
  • Bioresorbable polymer based stents    
  • Bioresorbable metallic stents
By Absorption Type:
  • Slow- absorption stents
  • Fast- absorption stents
By End Consumers:
  • Hospitals
  • Cardiac Centers
By Regional Analysis:
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Table of Contents

1 Introduction  
2 Market Research Tactics
2.1 Research Approach 
3 Market Summary
4 Quality Market Insights
5 Market Bioresorbable Stents Market Overview
6 Regulatory Market Synopsis
    6.1 Introduction
    6.2 Fda And Ce Approvals
    6.3 Pma Approvals And Government Certificates
7 Bioresorbable Stents Market, By Application
    7.1 Introduction
    7.2 Bioresorbable Metallic Stents
    7.3 Bioresorbable Polymer-Based Stents
8 Bioresorbable Stents Market, By Absorption Rate
9 Bioresorbable Stents Market, By Material
10 Bioresorbable Stents Market, By End Consumer
11 Bioresorbable Stents Market, By Geographic Region
12 Competitive Landscape
13 Company Profiles
     13.1 Abbott
     13.2 Reva Medical, Inc.
     13.3 Elixir Medical Corporation
     13.4 Kyoto Medical Planning  Co., Ltd.
     13.5 Biotronik
     13.6 Amaranth Medical, Inc.
     13.7 Arterial Remodeling Technologies
     13.8 Meril Life Sciences Pvt. Ltd.
     13.9 Arterius Limited
     13.10 Lepu Medical Technology Co., Ltd.
     13.11 Boston Scientific Corporation
     13.12 480 Biomedical
     13.13 S3v Vascular Technologies Private Limited
     13.14 Qualimed (Part Of Q3 Medical Group)
     13.15 Orbusneich

Media Contact
Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862
Country: United States

Comments

Popular posts from this blog

Capnography Devices Market is Supposed to Reach US$ 1.1 Billion By 2022

Fluoroscopy Equipment Market is Determined to Cross US$ 2.1 Billion By 2022

US Anticoagulation Therapy Market is Determined to Cross US$ 27 Billion By 2024